Defence Therapeutics Inc. Stock
Stocks
DTC
CA24463V1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
15:37:46 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 0.4900 CAD | 0.00% |
|
+2.08% | -31.94% |
| 08-31 | Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs | CI |
| 08-17 | Defence Therapeutics Inc. Announces Executive Changes | CI |
| Market Cap | 33.35M 23.82M 20.76M 19.58M 17.8M 2.29B 33.52M 234M 90.41M 1.16B 89.55M 87.56M 3.74B | P/E 2024 |
-2.5x | P/E 2025 | -9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 33.62M 24.01M 20.93M 19.74M 17.94M 2.3B 33.79M 236M 91.14M 1.17B 90.28M 88.28M 3.77B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
66.13% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| DTC | Delayed | |
Deutsche Boerse AG
| DTC | Delayed | |
|
Tradegate
| DTC | Real-time | |
|
Börse Stuttgart
| DTC | Delayed | |
|
OTC Markets
| DTCFF | Delayed | |
|
Boerse Muenchen
| DTC | Real-time |
| 1 week | +2.08% | ||
| Current month | -9.26% | ||
| 1 month | -2.00% | ||
| 3 months | +4.26% | ||
| 6 months | -16.95% | ||
| Current year | -31.94% |
| 1 week | 0.47 |  | 0.51 |
| 1 month | 0.47 | | 0.56 |
| Current year | 0.36 | | 0.74 |
| 1 year | 0.36 | | 0.93 |
| 3 years | 0.36 | | 3.01 |
| 5 years | 0.36 | | 7.5 |
| 10 years | 0.36 | | 8.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amie Phinney
CEO | Chief Executive Officer | - | 2026-07-31 |
Arnab De
DFI | Director of Finance/CFO | 55 | 2024-12-19 |
Ryan Simms
COO | Chief Operating Officer | - | 2026-08-16 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 53 | 2026-07-31 | |
| Director/Board Member | 64 | 2021-01-04 | |
| Director/Board Member | - | 2024-09-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/1/26 | Option | Chief Executive Officer | 200,000 | 0.2639% | ||
| 8/1/26 | Option | Founder | 200,000 | 0.2639% | ||
| 6/3/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.08% | -30.00% | -81.65% | 26.51M | |
| +0.11% | +2.71% | +0.44% | +26.85% | 46.28B | |
| -1.12% | +1.78% | +42.30% | +27.55% | 43.85B | |
| -3.04% | -6.29% | +338.56% | +515.97% | 40.93B | |
| -0.74% | +1.25% | +4.92% | +67.98% | 39.9B | |
| -0.50% | +0.67% | +11.79% | +40.51% | 29.5B | |
| -0.46% | +4.22% | +22.81% | +139.44% | 17.09B | |
| -0.97% | -10.17% | - | - | 15.55B | |
| -0.57% | +8.12% | +22.19% | +38.68% | 15.22B | |
| -3.14% | +31.91% | -11.79% | - | 14.05B | |
| Average | -1.04% | +3.39% | +44.58% | +96.92% | 26.24B | |
| Weighted average by Cap. | -1.10% | +1.87% | +68.21% | +130.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -13.19M -9.42M -8.21M -7.75M -7.04M -904M -13.26M -92.64M -35.77M -460M -35.43M -34.64M -1.48B | -3.52M -2.52M -2.19M -2.07M -1.88M -241M -3.54M -24.73M -9.55M -123M -9.46M -9.25M -395M |
| Net Debt | 1.69M 1.21M 1.05M 992K 902K 116M 1.7M 11.87M 4.58M 58.92M 4.54M 4.44M 189M | 272K 194K 169K 160K 145K 18.63M 273K 1.91M 737K 9.48M 730K 714K 30.48M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-17 | $0.4900 | -2.00% | 3,000 |
| 26-09-16 | $0.5000 | 0.00% | 7,500 |
| 26-09-15 | $0.5000 | +2.04% | 13,700 |
| 26-09-14 | $0.4900 | +2.08% | 35,810 |
| 26-09-11 | $0.4800 | -2.04% | 9,500 |
- Stock Market
- Stocks
- DTC Stock
Select your edition
All financial news and data tailored to specific country editions
